Ramaswamy Govindan

Trials

Studies that name Ramaswamy Govindan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:34 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT07155200 · Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)

  Washington University School of Medicine · recruiting · Small-cell Lung Cancer, Small Cell Lung Carcinoma, Small Cell Lung Cancer · principal investigator
• Ph1
  NCT03166254 · Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer

  Washington University School of Medicine · withdrawn · Non Small Cell Lung Cancer, NSCLC, Non-small Cell Lung Cancer · principal investigator
• N/A
  NCT02906852 · Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing

  Inivata · completed · Non-Small Cell Lung Cancer · principal investigator
• Ph2
  NCT02669914 · MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors

  Washington University School of Medicine · terminated · Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer, Breast Cancer · principal investigator
• N/A
  NCT02554591 · Genomic Landscape of Ceritinib

  Washington University School of Medicine · terminated · Carcinoma, Non-Small-Cell Lung, Non-small Lung Cancer, Non-Small Cell Lung Cancer · principal investigator
• N/A
  NCT02491775 · Afatinib Genomic Landscape

  Washington University School of Medicine · terminated · Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Non-small Lung Cancer · principal investigator
• Early Ph1
  NCT02419170 · Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)

  Washington University School of Medicine · withdrawn · Carcinoma, Non-Small-Cell-Lung, Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer · principal investigator
• Ph2
  NCT02299141 · Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer

  Washington University School of Medicine · completed · Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer · principal investigator
• Ph3
  NCT02193282 · Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

  National Cancer Institute (NCI) · active not recruiting · Lung Non-Squamous Non-Small Cell Carcinoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7 · principal investigator
• Ph2
  NCT01822496 · Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

  National Cancer Institute (NCI) · terminated · Stage III Non-Small Cell Lung Cancer AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7, Stage IIIB Non-Small Cell Lung Cancer AJCC v7 · principal investigator
• N/A
  NCT01414595 · Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer

  Alliance for Clinical Trials in Oncology · completed · Lung Cancer · study chair
• Ph1
  NCT00555256 · A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)

  Washington University School of Medicine · completed · Non-Small Cell Lung Cancer · principal investigator
• N/A
  NCT00484016 · Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC

  Washington University School of Medicine · completed · Adjuvant, Chemotherapy, Lung · principal investigator
• N/A
  NCT00483015 · Differences in the Presentation Outcome and Response to Treatment Between Never- Smokers and Smokers With NSCLC

  Washington University School of Medicine · completed · Smokers · principal investigator
• N/A
  NCT00424138 · FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy

  American College of Radiology Imaging Network · terminated · Lung Cancer · study chair
• Ph2
  NCT00352690 · A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer

  Washington University School of Medicine · terminated · Carcinoma, Non-Small-Cell Lung · principal investigator
• Ph2
  NCT00117962 · Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer

  Alliance for Clinical Trials in Oncology · completed · Lung Cancer · study chair
• Ph2
  NCT00025207 · Gefitinib in Treating Patients With Malignant Mesothelioma

  National Cancer Institute (NCI) · completed · Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma · principal investigator
• Ph2
  NCT00041054 · Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer

  Alliance for Clinical Trials in Oncology · completed · Lung Cancer · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer
  U01CA271402 · NCI · WASHINGTON UNIVERSITY · fiscal years 2022 to 2026 · $1,049,939 awarded in 2026
  Same name and institution; not confirmed by an ID
• Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology
  K12CA167540 · NCI · WASHINGTON UNIVERSITY · fiscal years 2012 to 2026 · $809,998 awarded in 2026
  Same name and institution; not confirmed by an ID
• Washington University PDX Development and Trial Center
  U54CA224083 · NCI · WASHINGTON UNIVERSITY · fiscal years 2017 to 2026 · $1,133,600 awarded in 2026
  Same name and institution; not confirmed by an ID
• Deep exploration of drivers, evolution, and microenvironment toward discovering principal themes in cancer
  U24CA264010 · NCI · WASHINGTON UNIVERSITY · fiscal years 2021 to 2025 · $380,063 awarded in 2025
  Same name and institution; not confirmed by an ID
• Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer
  U01CA231844 · NCI · WASHINGTON UNIVERSITY · fiscal years 2018 to 2022 · $567,348 awarded in 2022
  Same name and institution; not confirmed by an ID
• Deep Discovery and Clinical Interpretation of Germline and Somatic Cancer Drivers
  U24CA211006 · NCI · WASHINGTON UNIVERSITY · fiscal years 2016 to 2020 · $350,204 awarded in 2020
  Same name and institution; not confirmed by an ID
• Washington University Cancer Genomics and Outcomes Research STRENGTH Program
  R25CA190190 · NCI · WASHINGTON UNIVERSITY · fiscal years 2015 to 2019 · $194,032 awarded in 2019
  Same name and institution; not confirmed by an ID
• GENOMIC HARBINGERS OF BRAIN METASTASIS IN NON SMALL CELL LUNG CANCER
  R01CA182746 · NCI · WASHINGTON UNIVERSITY · fiscal years 2014 to 2018 · $316,438 awarded in 2018
  Same name and institution; not confirmed by an ID
• QUANTITATIVE DETECTION OF CLINICALLY ACTIONABLE MUTATIONS IN LUNG CANCER
  R21CA170063 · NCI · WASHINGTON UNIVERSITY · fiscal years 2013 to 2014 · $128,273 awarded in 2014
  Same name and institution; not confirmed by an ID
• ARRA: RECOVERY ACT - TISSUE SOURCE SITE (TSS) IN SUP
  26120100006 · NCI · WASHINGTON UNIVERSITY · fiscal years 2010 · $2,725,275 awarded in 2010
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Cancer and Leukemia Group B
  U10CA031946 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Monica M Bertagnolli · fiscal years 1985 to 2013
  Named on NCT02193282, NCT00117962, NCT00025207
• Alliance for Clinical Trials in Oncology Member Site Core
  U10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026
  Named on NCT02193282
• NCI NCTN- Network Lead Academic Participating Site: USC
  U10CA180830 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Anthony Boutros El-Khoueiry, HEINZ JOSEF LENZ, DAVID IAN QUINN · fiscal years 2014 to 2018
  Named on NCT02193282
• NRG Oncology Network Group Operations Center
  U10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Quynh-Thu Xuan Le, ROBERT S. MANNEL, NORMAN WOLMARK · fiscal years 2014 to 2026
  Named on NCT01822496
• Radiation Therapy Oncology Group
  U10CA021661 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Walter J. Curran · fiscal years 1985 to 2013
  Named on NCT01822496
• American College of Radiology Imaging Network
  U01CA080098 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI MITCHELL D. SCHNALL · fiscal years 1999 to 2011
  Named on NCT00424138
• Biostatistics Data Management Center for ACRIN
  U01CA079778 · NCI · BROWN UNIVERSITY · PI CONSTANTINE A. GATSONIS · fiscal years 1999 to 2011
  Named on NCT00424138